[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11575-11576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03628]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding OpportunityAnnouncements (FOAs) 
IP17-002, Improving HPV Vaccination Coverage among Adolescent Patients: 
A Randomized Controlled Trial of AFIX and Remote Physician-to-Physician 
Engagement Strategies and IP17-003, Rapid-Cycle Survey Collaborative 
for Provider Input on Immunization Issues.

TIME AND DATE: 10:00 a.m.-5:00 p.m., EDT, March 15, 2017 (Closed)

PLACE:  Teleconference

STATUS:  The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.

MATTERS FOR DISCUSSION:  The meeting will include the initial review, 
discussion, and evaluation of applications received in response to 
``Improving HPV Vaccination Coverage Among Adolescent Patients: A 
Randomized Controlled Trial of AFIX and Remote Physician-to-Physician

[[Page 11576]]

Engagement Strategies'', IP17-002 and ``Rapid-Cycle Survey 
Collaborative for Provider Input on Immunization Issues'', IP17-003.

CONTACT PERSON FOR MORE INFORMATION:  Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, 
Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-03628 Filed 2-23-17; 8:45 am]
 BILLING CODE 4163-18-P